Pratikkumar Vekaria
Pratikkumar Vekaria publishes mostly in Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine, on topics such as Long-Term Effects of COVID-19, Intensive Care Unit Cognitive Disorders and COVID-19 Clinical Research Studies.
- World rank
- #4,317,797 of 7,710,434 ranked researchers
- Rank in United States
- #1,159,423 of 1,627,098
- Works
- 36
- Citations
- 208
- Citations per work
- 5.8
What does Pratikkumar Vekaria research?
Pratikkumar Vekaria's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2261.4%
- Health Sciences1130.3%
- Medicine1130.3%
- Life Sciences38.3%
- 1Molecular Biology8% of their works
- 2Epidemiology7% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Oncology6% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Neurology5% of their works
Research topics
- Long-Term Effects of COVID-19
- Intensive Care Unit Cognitive Disorders
- COVID-19 Clinical Research Studies
- Endoplasmic Reticulum Stress and Disease
- Ubiquitin and proteasome pathways
- Venous Thromboembolism Diagnosis and Management
- Histone Deacetylase Inhibitors Research
- Drug-Induced Hepatotoxicity and Protection
Which keywords describe Pratikkumar Vekaria's research?
The keywords of their largest research topics: Cancer Therapy, Neurologic Manifestations, Oxidative Stress, Post-acute COVID-19 Syndrome, Clinical Characteristics, Delirium, Intensive Care Unit and SARS-CoV-2.
- Histone Deacetylases
- HDAC Inhibitors
- Venous Thromboembolism
- Stress
- Endoplasmic Reticulum
- SARS-CoV-2
- Delirium
- Post-acute COVID-19 Syndrome
- Neurologic Manifestations
- Cancer Therapy
- Oxidative Stress
- Clinical Characteristics
- Intensive Care Unit
- Antithrombotic Therapy
- Proteasome
- Ubiquitin
- Drug-Induced Liver Injury
- Hepatotoxicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer Therapy52 topics
- Neurologic Manifestations51 topic
- Oxidative Stress52 topics
- Post-acute COVID-19 Syndrome51 topic
- Clinical Characteristics41 topic
- Delirium41 topic
- Intensive Care Unit41 topic
- SARS-CoV-241 topic
- Antithrombotic Therapy31 topic
- Endoplasmic Reticulum31 topic
- Proteasome31 topic
- Stress31 topic
- Ubiquitin31 topic
- Venous Thromboembolism31 topic
- Drug-Induced Liver Injury21 topic
- HDAC Inhibitors21 topic
- Hepatotoxicity21 topic
- Histone Deacetylases21 topic
Where does Pratikkumar Vekaria work?
Pratikkumar Vekaria's main affiliation in the publication record is Prisma Health, United States.
How many publications and citations does Pratikkumar Vekaria have?
OpenAlex counts 36 works and 208 citations for Pratikkumar Vekaria, an h-index of 7, ranking #4,317,797 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pratikkumar Vekaria. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.